NovaBay Pharmaceuticals Inc Capital Reinvestment Ratio
NovaBay Pharmaceuticals Inc capital reinvestment ratio. NovaBay Pharmaceuticals Inc (NBY) has a Capital Reinvestment Ratio of 0.26x as of September 2017, meaning it reinvests 0% of its operating cash flow ($281.00K) in capital expenditures ($73.00K). Check NovaBay Pharmaceuticals Inc (NBY) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of NovaBay Pharmaceuticals Inc (2006–2010)
Capital reinvestment ratio of NovaBay Pharmaceuticals Inc from 2006 to 2010. This chart tracks NovaBay Pharmaceuticals Inc's Capital Reinvestment Ratio across 2 annual periods. Also explore NovaBay Pharmaceuticals Inc net asset momentum to track the company's year-over-year net asset growth rate.
NovaBay Pharmaceuticals Inc Capital Reinvestment Ratio by Year (2006–2010)
NovaBay Pharmaceuticals Inc capital reinvestment ratio by year from 2006 to 2010. For the full cash flow conversion analysis, see NBY operating cash flow.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2010 | 0.10x | $2.03 Million | $203.00K | ▲ +31.2% |
| 2006 | 0.08x | $4.74 Million | $362.00K | — |